Cargando…
Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia
Aripiprazole has been reported to exert variable effects on cognitive function in patients with schizophrenia. Therefore, in the present study, we evaluated biological markers, clinical data, and psychiatric symptoms in order to identify factors that influence cognitive function in patients with sch...
Autores principales: | Hori, Hikaru, Yoshimura, Reiji, Katsuki, Asuka, Atake, Kiyokazu, Igata, Ryohei, Konishi, Yuki, Beppu, Hiroki, Tominaga, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372584/ https://www.ncbi.nlm.nih.gov/pubmed/28272307 http://dx.doi.org/10.3390/ijms18030568 |
Ejemplares similares
-
Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study
por: Konishi, Yuki, et al.
Publicado: (2018) -
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura, Reiji, et al.
Publicado: (2017) -
Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018) -
The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
por: Atake, Kiyokazu, et al.
Publicado: (2018) -
Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
por: Yoshimura, Reiji, et al.
Publicado: (2016)